Mr. Craig MacPhail reports

NUMINUS APPLIES FOR MANAGEMENT CEASE TRADE ORDER

Numinus Wellness Inc. has requested a temporary management cease trade order from the B.C. Securities Commission in connection with the company's filing of its audited annual financial statements and management's discussion and analysis for the financial year ended Aug. 31, 2024.

The company is requesting the MCTO to secure additional time to finalize its audited financial statements, the related MD&A, and the applicable chief executive officer and chief financial officer certifications. The delay in filing the annual filings is a result of unexpected delays experienced by the company. The company is working with its accounting team to prepare the financial statements and respond to all queries. It is the company's reasonable expectation that the annual filings will be finalized by the end of the year.

By way of background and as required by the BCSC, the company notes the following:

1. The company is required to file its annual filings all in accordance with international financial reporting standards within 120 days after the end of its completed financial year, such date being Nov. 29, 2024, as required by National Instrument 51-102 (Continuous Disclosure Obligations). The company does not anticipate that it will be able to complete the annual filings on or before the annual filing deadline.
2. The company is working diligently to prepare and file the annual filings by the end of the year, subject to its auditor's staff availability.
3. The company confirms that it intends to issue a status report on a biweekly basis, for as long as it remains in default of the annual filing deadline in respect of the annual filings.
4. The company is not subject to any insolvency proceedings.
5. There is no other material information concerning the affairs of the company that has not been generally disclosed.

The company has imposed an insider trading blackout pending the filing of the annual filings and will comply with the alternative information guidelines described in National Policy 12-203 (Management Cease Trade Orders) during such period.

About Numinus Wellness Inc.

Numinus helps people to heal and be well through the development and delivery of innovative mental health care and access to safe evidence-based psychedelic-assisted therapies. The Numinus model -- including psychedelic research and clinic care -- is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, it is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

We seek Safe Harbor.